Supplementary Table S15 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S15 shows the results of weighted multiple linear regression analysis of log-transformed urinary N’-nitrosoanatabine with study covariates</p

Supplementary Table S37 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S37 shows the results of weighted multiple linear regression analysis of log-transformed urinary phenylmercapturic acid (PhMA) with study covariates</p

Supplementary Table S24 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S24 shows the results of weighted multiple linear regression analysis of log-transformed urinary 3,4-methylhippuric acid (34MHA) with study covariates</p

Supplementary Table S35 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S35 shows the results of weighted multiple linear regression analysis of log-transformed urinary N‐acetyl‐S‐(4‐hydroxy‐2‐methyl‐2‐buten‐1‐yl)‐L‐cysteine (4HMBeMA) with study covariates</p

Supplementary Table S41 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S41 shows scaled variance components and intra-class correlation coefficients resulting from mixed model analysis for all analytes</p

Supplementary Table S12 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S12 shows the results of weighted multiple linear regression analysis of log-transformed urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) with study covariates</p

Supplementary Table S11 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S11 shows the results of weighted multiple linear regression analysis of log-transformed urinary anatabine with study covariates</p

Supplementary Table S14 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S14 shows the results of weighted multiple linear regression analysis of log-transformed urinary N’-nitrosoanabasine with study covariates</p

Supplementary Table S26 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S26 shows the results of weighted multiple linear regression analysis of log-transformed urinary N‐acetyl‐S‐(3,4‐dihydroxybutyl)‐L‐cysteine (34HBMA) with study covariates</p

Supplementary Table S17 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S17 shows the results of weighted multiple linear regression analysis of log-transformed urinary 1-naphthol with study covariates</p